FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia.
Ratings
1 / 5
1 rating in the last 12 months
5
4
3
2
1
CEO
Mr. Thane Wettig$122.4M
Market Cap • 25/07/20241993
(há 31 anos)
2014
(10 years ago)
NASDAQ
Listagem
San Francisco
Sede • California592
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
FGENSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.